Log in or Sign up for Free to view tailored content for your specialty!
Preventive Medicine News
PCPs misdiagnose about 1 in 4 cases of iron deficiency anemia
Many primary care physicians may be overusing laboratory tests for anemia screening, misinterpreting iron studies and underusing bidirectional endoscopy for new-onset iron deficiency anemia, according to a recent survey study.
Q&A: Amidst COVID-19, anti-Asian racism adds to public health crisis
While the COVID-19 pandemic has put an incredible burden on all health care workers, it has also fueled a resurgence of anti-Asian racism in the U.S. and highlighted disparities in health care research and opportunities for Asian Americans.
Log in or Sign up for Free to view tailored content for your specialty!
Pfizer, BioNTech formally ask FDA to authorize vaccine in kids aged 5 to 11 years
Pfizer and BioNTech said Thursday that they have submitted a request to the FDA for an emergency use authorization of their COVID-19 vaccine in children aged 5 to 11 years.
Adding new antihypertensive to current therapy may reduce BP more than maximizing dose
Adding a new medication to older adults’ antihypertension treatment regimen produced a slightly greater reduction in systolic BP than maximizing dosage, according to findings published in Annals of Internal Medicine.
‘Good news’: Healthful plant-based diets lower risk for urological conditions in men
Men who ate healthy plant-based diets lowered their risk for prostate cancer and erectile dysfunction, according to data from three abstracts that were presented during the virtual American Urological Association meeting.
While rare, myocarditis after COVID-19 vaccination is more common in young men
Acute myocarditis was rare in individuals who received at least one dose of the Pfizer-BioNTech or Moderna COVID-19 vaccine, according to findings published in JAMA Internal Medicine.
Red Cross asks for routine blood donations amid national shortage
The national blood inventory is at its lowest level for this time of the year since 2015, according to the Red Cross.
Antiviral reduces risk for hospitalization, death by about 50% in patients with COVID-19
Molnupiravir, an investigational oral antiviral drug, significantly reduced the risk for hospitalization or death from COVID-19 among high-risk patients, according to a company press release.
AstraZeneca COVID-19 vaccine 74% effective, protects against asymptomatic disease
Recent findings in The New England Journal of Medicine showed that AstraZeneca’s two-dose COVID-19 vaccine was 74% effective against symptomatic disease.
Q&A: Internist shares screening tips during Prostate Cancer Awareness Month
Prostate cancer is the second-most common cancer among men in the United States, with one in eight men diagnosed with the condition during his lifetime, data from the American Cancer Society show.
-
Headline News
Q&A: Cuts to 2025 physician fee schedule yield ‘catastrophic’ impacts to patient access
November 11, 20246 min read -
Headline News
Daily oral semaglutide confers weight loss vs. placebo; similar vs. weekly injectables
November 11, 20243 min read -
Headline News
Culture shift needed to reframe cybersecurity as a patient safety issue
November 11, 202410 min read
-
Headline News
Q&A: Cuts to 2025 physician fee schedule yield ‘catastrophic’ impacts to patient access
November 11, 20246 min read -
Headline News
Daily oral semaglutide confers weight loss vs. placebo; similar vs. weekly injectables
November 11, 20243 min read -
Headline News
Culture shift needed to reframe cybersecurity as a patient safety issue
November 11, 202410 min read